Insight Molecular Diagnostics (IMDX) Total Debt (2013 - 2026)
Insight Molecular Diagnostics (IMDX) total debt from Dec 31, 2013 to Mar 31, 2026. The current Insight Molecular Diagnostics (IMDX) total debt is $51M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Debt
Total Debt
Insight Molecular Diagnostics (IMDX) Total Debt CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +0.41% |
| 3 Years TTM | -6.52% |
| 5 Years TTM | +18.14% |
| 10 Years TTM | +45.21% |
Annual Total Debt change of Insight Molecular Diagnostics (IMDX)
| Year | Total Debt | Change |
|---|---|---|
| 2025 | $57M | +20.82% |
| 2024 | $47M | -3.94% |
| 2023 | $49M | -18.51% |
| 2022 | $61M | -35.88% |
| 2021 | $94M | +330.04% |
| 2020 | $22M | +143.24% |
| 2019 | $9.02M | +47.87% |
| 2018 | $6.10M | +4.99% |
| 2017 | $5.81M | +26.58% |
| 2016 | $4.59M | +98.70% |
| 2015 | $2.31M | N/A |
| 2014 | $0 | N/A |
| 2013 | $0 | N/A |
Comparison Insight Molecular Diagnostics (IMDX) total debt with competitors
Insight Molecular Diagnostics (IMDX) total debt is $51.12M.